All Stories

  1. Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry
  2. Attainment of low-density lipoprotein cholesterol target in patients with coronary heart disease: Still a long way to go
  3. Determinants of participation and risk factor control according to attendance in cardiac rehabilitation programmes in coronary patients in Europe: EUROASPIRE IV survey
  4. Lifestyle and risk factor management in people at high risk of cardiovascular disease. A report from the European Society of Cardiology European Action on Secondary and Primary Prevention by Intervention to Reduce Events (EUROASPIRE) IV cross-sectional...
  5. Lipid lowering drug therapy in patients with coronary heart disease from 24 European countries – Findings from the EUROASPIRE IV survey
  6. The use of HeartQoL in patients with coronary heart disease: Association with risk factors and European reference values. The EUROASPIRE IV study of the European Society of Cardiology
  7. Implementation of Cardiovascular Disease Prevention Guidelines in Clinical Practice—Can We Do Better?
  8. Latest EUROASPIRE Surveys Reveal Continuing Health Concerns
  9. Validity and reliability of the HeartQoL questionnaire in a large sample of stable coronary patients: The EUROASPIRE IV Study of the European Society of Cardiology
  10. Educational level and risk profile and risk control in patients with coronary heart disease
  11. Prevalence and management of familial hypercholesterolaemia in coronary patients: An analysis of EUROASPIRE IV, a study of the European Society of Cardiology
  12. Evaluation of preventive cardiology
  13. 149 Lifestyle, Blood Pressure, Lipids and Diabetes Management in Patients with Coronary Heart Disease From 24 Countries in Europe
  14. Comparison of treatment outcomes in patients with and without diabetes mellitus attending a multidisciplinary cardiovascular prevention programme (a retrospective analysis of the EUROACTION trial)
  15. EUROASPIRE IV survey: Management of coronary patients in Europe
  16. Validity and reliability of the HeartQoL questionnaire based on the EUROASPIRE IV study
  17. Readiness for smoking cessation in coronary heart disease patients across Europe: Results from the EUROASPIRE III survey
  18. Which statin worked best to achieve lipid level targets in a European registry? A post-hoc analysis of the EUROASPIRE III for coronary heart disease patients
  19. Risk factor awareness in a coronary population and the association with health-related quality of life outcomes
  20. Does pharmacologic treatment in patients with established coronary artery disease and diabetes fulfil guideline recommended targets? A report from the EUROASPIRE III cross-sectional study
  21. TIME TRENDS IN CARDIOVASCULAR RISK FACTOR MANAGEMENT IN CORONARY PATIENTS IN EUROPE: RESULTS FROM THREE EUROASPIRE SURVEYS 1999-2013
  22. Effectiveness of a preventive cardiology programme for high CVD risk persistent smokers: the EUROACTION PLUS varenicline trial
  23. O192 Clinical reality of coronary prevention in Europe: A comparison of EUROASPIRE II, III and IV surveys
  24. Self-reported health status in coronary heart disease patients: A comparison with the general population
  25. Treatment potential for dyslipidaemia management in patients with coronary heart disease across Europe: Findings from the EUROASPIRE III survey
  26. Health related quality of life in coronary patients and its association with their cardiovascular risk profile: Results from the EUROASPIRE III survey
  27. Residual risk of cardiovascular mortality in patients with coronary heart disease: The EUROASPIRE Risk Categories
  28. Validity and reliability of three commonly used quality of life measures in a large European population of coronary heart disease patients
  29. The association between self‐reported lifestyle changes and health-related quality of life in coronary patients: the EUROASPIRE III survey
  30. Cost-effectiveness of a European preventive cardiology programme in primary care: a Markov modelling approach
  31. 165 DOES FRUIT AND VEGETABLE CONSUMPTION INFLUENCE THE QUANTUM OF BLOOD PRESSURE LOWERING THERAPY REQUIRED TO ACHIEVE BLOOD PRESSURE TARGETS IN PATIENTS WITH CORONARY HEART DISEASE?
  32. Cost-effectiveness of optimizing prevention in patients with coronary heart disease: the EUROASPIRE III health economics project
  33. Use and effects of cardiac rehabilitation in patients with coronary heart disease: results from the EUROASPIRE III survey
  34. 144 Nurses meet the challenge of helping high CVD risk smokers to quit with the help of varenicline in a preventive cardiology programme
  35. 145 EUROACTION PLUS: a randomised controlled trial on preventive cardiology programme plus intensive smoking cessation with Varenicline for vascular and high CVD risk smokers and their partners--principal results
  36. Determinants of risk factor control in subjects with coronary heart disease: a report from the EUROASPIRE III investigators
  37. Depression, anxiety, and risk factor control in patients after hospitalization for coronary heart disease: the EUROASPIRE III Study
  38. Blood pressure control and knowledge of target blood pressure in coronary patients across Europe
  39. ADVERSE EFFECT OF VARIOUS CLINICAL AND GEOGRAPHICAL FACTORS ON BLOOD PRESSURE OUTCOMES IN PATIENTS WITH CORONARY HEART DISEASE
  40. THE IMPACT OF FRUIT AND VEGETABLE INTAKE ON BLOOD PRESSURE IN PATIENTS WITH CORONARY HEART DISEASE
  41. CONCORDANCE OF HEALTHY EATING BEHAVIOURS AND LIFESTYLE IN PATIENTS WITH CORONARY HEART DISEASE UNDER MULTIDISCIPLINARY CARE
  42. Gender differences in the implementation of cardiovascular prevention measures after an acute coronary event
  43. EUROASPIRE III. Management of cardiovascular risk factors in asymptomatic high-risk patients in general practice: cross-sectional survey in 12 European countries
  44. Management of overweight and obese patients with coronary heart disease across Europe
  45. 118 ASPIRE-2-PREVENT: lifestyle and risk factor management in people at high risk of developing cardiovascular disease in the UK
  46. 115 ASPIRE-2-PREVENT: a British cardiovascular society survey on the lifestyle and risk factor management and use of cardioprotective medication in coronary patients in the UK
  47. 116 Prevalence of persistent lipid abnormalities in high-risk patients treated with statins: results of the dyslipidemia international study in the UK
  48. 63 Poster Moderated Risk Factor Changes in Coronary and High Cardiovascular Disease Risk Patients and their Partners Attending the MYACTION Integrated Vascular Prevention Programme in the Community
  49. 64 Poster Moderated Health Related Quality of life Changes in Coronary and High Cardiovascular Risk Patients and their Partners Attending the MYACTION Integrated Vascular Prevention Programme in the Community
  50. 176 Poster Changes in Lifestyle, Anthropometric Measures and Function in a Novel Family-Centred Preventive Cardiology Programme in the Community
  51. El tratamiento de pacientes con enfermedad coronaria no cumple las normas de las guías europeas: resultados de las encuestas EUROASPIRE
  52. Treatment of Patients With Coronary Heart Disease Fails to Meet Standards of European Guidelines: Results of EUROASPIRE Surveys
  53. The challenge for preventive cardiology
  54. EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries
  55. SMMP1 Euroaspire III Survey in General Practice. Lifestyle, Risk Factor and Therapeutic Management in People at High Risk of Developing Cardiovascular Disease from 12 European Regions
  56. Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries
  57. Preventive Cardiology
  58. Identification and recruitment
  59. Changing lifestyles
  60. The nurse-led multidisciplinary team
  61. Smoking cessation
  62. Physical activity and exercise
  63. Comprehensive multidisciplinary family-based cardiovascular assessment
  64. Principles of dietary intervention
  65. Principles of managing weight loss
  66. Blood pressure, lipids and glucose
  67. Erectile dysfunction
  68. Data management, quality assurance, and audit
  69. Cardioprotective drug therapies
  70. The health promotion workshop programme
  71. Rationale for preventive cardiology programmes
  72. Políticas preventivas globales. Estrategias a escala europea y mundial
  73. EUROASPIRE III: LIFESTYLE AND RISK FACTOR MANAGEMENT AND USE OF DRUG THERAPIES IN CORONARY PATIENTS FROM 22 COUNTRIES IN EUROPE
  74. Treatment potential for cholesterol management in patients with coronary heart disease in 15 European countries: Findings from the EUROASPIRE II survey
  75. 1343 Reported lifestyle habits in coronary patients and access to cardiac rehabilitation in the EUROASPIRE III survey
  76. 1349 EUROASPIRE III: Lifestyle and risk factor management and use of drug therapies in coronary patients from 22 countries in Europe
  77. 1351 Changes in lifestyle habits and cardiovascular risk factors over one-year in a family based preventive cardiology programme in hospital and general practice: Results from EUROACTION
  78. 1344 Time trends in smoking in coronary patients the EUROASPIRE surveys I, II and III in 8 countries
  79. 1345 EUROACTION: Do couples attending a hospital based multidisciplinary family cardiovascular prevention and rehabilitation programme share the same risk factors? Do they change together?
  80. Global Preventive Policies. Strategies at European and Worldwide Level
  81. EUROACTION: An ESC project in preventive cardiology programme in coronary and high risk patients and their partners
  82. EUROACTION
  83. LB-OR-1 EUROACTION: A EUROPEAN SOCIETY OF CARDIOLOGY DEMONSTRATION PROJECT IN PREVENTIVE CARDIOLOGY PROGRAMME IN ASYMPTOMATIC HIGH RISK PATIENTS AND THEIR PARTNERS
  84. PO13-331 EUROACTION: A EUROPEAN SOCIETY OF CARDIOLOGY DEMONSTRATION PROJECT IN PREVENTIVE CARDIOLOGY PROGRAMME IN CORONARY PATIENTS AND THEIR PARTNERS
  85. PO13-337 EUROACTION: A EUROPEAN SOCIETY OF CARDIOLOGY DEMONSTRATION PROJECT IN PREVENTIVE CARDIOLOGY PROGRAMME IN ASYMPTOMATIC HIGH RISK PATIENTS AND THEIR PARTNERS
  86. EUROACTION
  87. EUROACTION
  88. 1402: EuroAction: A nurse-led multidisciplinary cardiovascular prevention and rehabitation hospital programme. 16-week results
  89. 1401: EuroAction: The challenge for a nurse-led cardiovascular prevention pogramme in primary care
  90. Euroaction: the physical activity challenge for a cardiovascular prevention programme in primary care
  91. Euroaction: identification, eligibility and participation in a nurse-led multidisciplinary hospital based cardiovascular prevention and rehabilitation programme
  92. Euroaction: a cardiovascular prevention and rehabilitation hospital programme???the physical activity results
  93. Euroaction: challenges for nurses working in preventive cardiology???smoking behaviour in high risk patients and their partners in primary care
  94. Euroaction: challenges for nurses working in preventive cardiology???smoking behaviour in coronary patients and their partners
  95. Euroaction: a cardiovascular prevention and rehabilitation hospital programme???blood pressure, lipid and glucose levels
  96. Euroaction: the challenge for a preventive cardiology programme in primary care
  97. Euroaction: the dietetic challenge for a preventive cardiology programme in primary care
  98. Euroaction: a cardiovascular prevention and rehabilitation hospital programme???the use of cardioprotective medication
  99. Euroaction: a preventive cardiology programme in primary care???the identification of high risk individuals
  100. Euroaction: a cardiovascular prevention and rehabilitation programme???the 16-week obesity results
  101. Euroaction: a cardiovascular prevention and rehabilitation programme???the dietetic results
  102. Risk scores for management and prevention of cardiovascular disease
  103. Blood pressure is insufficiently controlled in European patients with established coronary heart disease
  104. Decreased carotid artery distensibility as a sign of early atherosclerosis in viscose rayon workers
  105. Euroaspire II: therapeutic control of blood cholesterol in patients with coronary heart disease in 15 European countries
  106. Euroaspire II: risk factor management and use of prophylactic drug therapy in patients with coronary heart disease in Europe
  107. Cardiovascular Effects in Viscose Rayon Workers Exposed to Carbon Disulfide
  108. Cardiovascular Effects in Viscose Rayon Workers Exposed to Carbon Disulfide
  109. Occupational exposure to low concentrations of carbon disulfide as a risk factor for hypercholesterolaemia
  110. Cardiovascular Effects of Occupational Exposure to Carbon Disulphide
  111. Five year follow-up study of the incidence of arterial hypertension and coronary heart disease in vinyl chloride monomer and polyvinyl chloride production workers